TORL BioTherapeutics intends to use the funds to advance its TORL-1-23 and TORL-...
SAB Biotherapeutics received regulatory support to advance SAB-176 into a Phase ...
Lilly recently secured Japanese approval for mirikizumab as a first-in-class tre...
AVT02, which is a monoclonal antibody, is under review by the US FDA.
A wide range of host cell lines are used in bioprocessing, from Chinese hamster ...
GIVI-MPC received an orphan drug designation (ODD) from the FDA in February 2023.
Both libraries include combinations of tailor-made gene parts that are shuffled ...
The collaboration will discover and develop a GD2 CAR T-cell therapeutic candida...
The revised report reveals the fair pricing benchmarks for two NASH treatments, ...
The West African country has approved the vaccine for use in children ages betwe...
Amid increasing scrutiny of pharmacy benefit managers, Express Scripts is launch...
Congress is launching a tobacco harm reduction caucus. Its biggest supporter so ...
MedPAC wants Medicare to cap payments for drugs that the FDA greenlit via its ac...
Is pharma facing an existential threat? How do you get CEOs to speak out? And wh...
There are a lot of ways that AI can go awry in health and medicine. A team of re...
Manuela Thienel and her 38 collaborators — it takes a village to study a bear — ...
